| Vascular complications after balloon and new device angioplasty. | |
| | |
MedLine Citation:
|
PMID: 8403304 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Despite their potential advantages, new coronary angioplasty devices may be associated with more frequent vascular complications than noted after standard balloon angioplasty, theoretically due to the larger sheaths and prolonged periods of anticoagulation required by some of these devices. This study sought to identify the incidence, predictors, and clinical outcome of vascular complications after new device angioplasty. METHODS AND RESULTS: The clinical course of 1413 patients was reviewed after balloon or new device angioplasty. Vascular complications were defined as formation of a pseudoaneurysm, arteriovenous fistula, retroperitoneal hematoma, or groin hematoma associated with a > 15-point hematocrit drop or the need for surgical repair. Stepwise logistic regression was used to identify independent predictors for vascular complications. Vascular complications developed after 84 (5.9%) procedures; they occurred more frequently after intracoronary stenting (14.0%) and extraction atherectomy (12.5%) than after balloon angioplasty (3.2%) (odds ratios, 4.86; P < .001, and 4.26, P < .05, respectively). Independent predictors of vascular complications included the use of intraprocedural thrombolytic agents (P < .01), intracoronary stenting (P < .005), or extraction atherectomy (P < .05); high maximum creatinine level (P < .005); low nadir platelet count (P < .001); longer periods of excess anticoagulation (P < .05); and the need for repeat coronary angioplasty (P < .005). Vascular complications were not related to the size of the arterial sheath used. CONCLUSIONS: Vascular complications developed more frequently after new device angioplasty than after balloon angioplasty, with the risk for vascular complications directly related to the degree of periprocedural anticoagulation. |
| | |
Authors:
|
J J Popma; L F Satler; A D Pichard; K M Kent; A Campbell; Y C Chuang; C Clark; A J Merritt; T A Bucher; M B Leon |
Related Documents
:
|
11287714 - Primary angioplasty in acute inferior myocardial infarction with anomalous-origin right... 8122614 - Incidence, predictors, and management of acute coronary occlusion after coronary angiop... 2317854 - "high-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic... 9266794 - Comparison of 6f with 7f and 8f guiding catheters for elective coronary angioplasty: re... 17966554 - Superior biatrial septotomy and beating heart approach for aortic and mitral valve repl... 8447204 - Effects of low-dose adenosine on myocardial performance after coronary artery bypass su... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Circulation Volume: 88 ISSN: 0009-7322 ISO Abbreviation: Circulation Publication Date: 1993 Oct |
Date Detail:
|
Created Date: 1993-11-04 Completed Date: 1993-11-04 Revised Date: 2010-03-24 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1569-78 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine Cardiology Division, Washington Hospital Center, Washington, DC 20010. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aneurysm, False
/
epidemiology Angioplasty, Balloon, Laser-Assisted / adverse effects*, instrumentation Angioplasty, Transluminal, Percutaneous Coronary / adverse effects*, instrumentation Arteriovenous Fistula / epidemiology Atherectomy, Coronary / adverse effects*, instrumentation Causality Equipment Design Female Hematoma / epidemiology Humans Logistic Models Male Middle Aged Prevalence Risk Factors Stents / adverse effects* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Angiographic-pathologic correlations after elective percutaneous transluminal coronary angioplasty.
Next Document: Predicting early and intermediate-term outcome of coronary angioplasty in the elderly.